Tres Alchemix
Tres Alchemix uses quantum chemistry and AI to predict how molecules behave in the body and accelerate drug discovery. The company combines quantum-level chemical calculations, multi-omics AI, and predictive machine learning models to estimate chemical–protein interactions, pharmacokinetics, and pharmacodynamics. Tres Alchemix is a B2B AI biotechnology platform that works with pharmaceutical companies, drug developers, and research institutions. Founded in 2023 with an R&D hub in Oxford, it partners with academic and industry collaborators to support in silico human modeling and novel therapeutic discovery.
Tres Alchemix
Tres Alchemix uses quantum chemistry and AI to predict how molecules behave in the body and accelerate drug discovery. The company combines quantum-level chemical calculations, multi-omics AI, and predictive machine learning models to estimate chemical–protein interactions, pharmacokinetics, and pharmacodynamics. Tres Alchemix is a B2B AI biotechnology platform that works with pharmaceutical companies, drug developers, and research institutions. Founded in 2023 with an R&D hub in Oxford, it partners with academic and industry collaborators to support in silico human modeling and novel therapeutic discovery.